APA

Kristal A. R., Price D. K., Till C., Schenk J. M., Neuhouser M. L., Ockers S., Lin D. W., Thompson I. M. & Figg W. D. (20100415). Androgen receptor CAG repeat length is not associated with the risk of incident symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial. : The Prostate.

Chicago

Kristal Alan R, Price Douglas K, Till Cathee, Schenk Jeannette M, Neuhouser Marian L, Ockers Sandy, Lin Daniel W, Thompson Ian M and Figg William D. 20100415. Androgen receptor CAG repeat length is not associated with the risk of incident symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial. : The Prostate.

Harvard

Kristal A. R., Price D. K., Till C., Schenk J. M., Neuhouser M. L., Ockers S., Lin D. W., Thompson I. M. and Figg W. D. (20100415). Androgen receptor CAG repeat length is not associated with the risk of incident symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial. : The Prostate.

MLA

Kristal Alan R, Price Douglas K, Till Cathee, Schenk Jeannette M, Neuhouser Marian L, Ockers Sandy, Lin Daniel W, Thompson Ian M and Figg William D. Androgen receptor CAG repeat length is not associated with the risk of incident symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial. : The Prostate. 20100415.